Neuvotion, a Darien, CT-based medical device company, raised over $1M in Seed funding.
The round was led by Long Island Angel Network and the Good Shepherd Rehabilitation Network.
The company intends to use the funds to expand its team, conduct a multi-site clinical study, and seek FDA clearance for its initial product..
Led by Chad Bouton, Founder & CEO, Neuvotion is an early-stage medical device company developing solutions for facilitating and restoring movement to the millions of patients experiencing impairment from stroke, traumatic injury, and other conditions. Its NeuStim™ technology combines highly targeted neurostimulation and artificial intelligence to make physical and occupational therapy more effective and efficient. Neuvotion is planning a multi-site clinical study to begin next year.
The company company has received exclusive worldwide license from Northwell Health.